Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122947 · ClinicalTrials.gov registry record
Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF
A clinical trial of Atrial Fibrillation, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 75
- Enrollment target
- 2
- Study locations
NCT07122947 is a study of Atrial Fibrillation that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 75 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07122947, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective multicenter clinical study comparing the efficacy of the Apple Watch AFib History tool to the iRhythm Zio Patch monitoring device in quantifying atrial fibrillation (AF) burden after surgical ablation. Patients with AF and mitral valve (MV) disease who undergo a Cox-Maze IV procedure concomitant to MV surgery will be evaluated at serial timepoints for up to 1 year postoperatively. The trial will be conducted in the United States at the Cleveland Clinic in Cleveland, OH and at the Washington University School of Medicine in St. Louis, MO.
Conditions Studied
Interventions
- DEVICE Apple Watch: AFib History
- DEVICE Zio Patch
Study Locations (2)
Missouri
- Washington University School of Medicine in St. Louis - St Louis
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-06-02 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07122947
The ClinicalTrials.gov registry entry for NCT07122947 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Apple Watch: AFib History is the first listed.
NCT07122947 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT07122947 about?
NCT07122947 is a clinical study titled "Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF". This is a prospective multicenter clinical study comparing the efficacy of the Apple Watch AFib History tool to the iRhythm Zio Patch monitoring device in quantifying atrial fibrillation (AF) burden after surgical ablation. Patients with AF and mitral valve (MV) disease who undergo a Cox-Maze IV pro...
What is the current status of trial NCT07122947?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-06-02. Estimated completion is 2027-12-31.
What conditions does trial NCT07122947 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT07122947?
The interventions under investigation include: Apple Watch: AFib History (DEVICE), Zio Patch (DEVICE).
Who is sponsoring clinical trial NCT07122947?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07122947 being conducted?
This trial has 2 study locations across Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.